Physician
Internal Medicine
Dr. Stephen E. Spurgeon, MD
|
|
Give Review
Stephen Spurgeon is an expert in the field of Internal Medicine. He researched medicine at Jefferson Medical College. He received awards:"CMS Meaningful Use Stage 1 Certification". Stephen Spurgeon is also a published doctor. He has 17 publication published. The most recent publication is: MYD88 mutation analysis of a rare composite chronic lymphocyte leukemia and lymphoplasmacytic lymphoma by flow cytometry cell sorting. He is registered with Medicare and accepts Medicare payments.
Publications
- MYD88 mutation analysis of a rare composite chronic lymphocyte Leukemia and lymphoplasmacytic lymphoma by flow cytometry cell sorting.
- Otlertuzumab (TRU-016), an anti-CD37 monospecific ADAPTIR(™) therapeutic protein, for relapsed or refractory NHL patients.
- Aberrations of MYC Are a Common Event in B-Cell Prolymphocytic Leukemia.
- Idelalisib, a selective inhibitor of phosphatidylinositol 3-kinase-δ, as therapy for previously treated indolent non-Hodgkin Lymphoma.
- Idelalisib, an inhibitor of phosphatidylinositol 3 kinase p110δ, for relapsed/refractory chronic lymphocytic Leukemia.
- A potential therapeutic strategy for chronic lymphocytic Leukemia by combining Idelalisib and GS-9973, a novel spleen tyrosine kinase (Syk) inhibitor.
- CX-4945, a selective inhibitor of casein kinase 2 (CK2), exhibits anti-tumor activity in hematologic malignancies including enhanced activity in Chronic lymphocytic le...
- The selective Syk inhibitor P505-15 inhibits B cell signaling and function in vitro and in vivo, and augments the activity of fludarabine in chronic lymphocytic Leukemia.
- Kinase Pathway Dependence in Primary Human Leukemias Determined by Rapid Inhibitor Screening.
- Reversible pulmonary toxicity due to lenalidomide.
- Survival trends in Mantle cell Lymphoma in the United States over sixteen years 1992-2007.
- Cladribine plus rituximab is an effective therapy for newly diagnosed mantle cell Lymphoma.
- Acute promyelocytic leukemia with JAK2 V617F and severe differentiation syndrome.
- Cladribine: not just another purine analogue?
- Assessment of prostate-specific antigen doubling time in prediction of prostate cancer on needle biopsy.
- Classification and regression tree analysis for the prediction of aggressive prostate cancer on biopsy.
Schools
Thomas Jefferson University
Or Health Science University Hospital
Procedures Preformed
- HPC Transplantation (Stem Cell Transplant)
- Plasmapheresis
Conditions Treated
- Acute Leukemia
- Anemia
- Burkitt's Lymphoma
- Central Nervous System Lymphoma
- View All
Doctors Specialties
- Hematology
- Internal Medicine
Accepted Insurances
- Choice Plus POS II
- Blue Card PPO
- Cigna PPO
- Great West Healthcare-Cigna PPO
- Open Access Plus
- Commercial Insurance Company
- First Choice Health PPO
- First Health (Coventry Health Care) PPO
- Health Plan of Oregon PPO
- Medicare Advantage PFFS
- Humana
- Kaiser Permanente
- Medicaid
- Medicare MCR
- ODS Health Plan
- Preferred PSN
- Heritage Plus
- Heritage Signature
- Preferred PPO
- Preferred Provider Network PPN
- Thrivent Financial
- Tricare
- Choice Plus POS
- Options PPO
- PacifiCare HMO
- United Healthcare
Awards
- CMS Meaningful Use Stage 1 Certification
Education
-
Oregon Health & Science University -
Jefferson Medical College
Drug Facts
| NPI NUMBER | 1194730606 | |
| NPPES Provider LastName | SPURGEON | |
| NPPES Provider FirstName | STEPHEN | |
| NPPES Provider ZIPCode | 972393011 | |
| NPPES Provider State | OR | |
| Specialty Description | Hematology/Oncology | |
| Total Claim Count | 274.0 | |
| Distinct Opioid Count | 0.0 | |
| Opioid Claim Count | 0.0 | |
| Percent Opioid Claims | 0.0 |
Helpful Reviews
Medicare Facts
| National Provider Identifier [NPI] | 1194730606 |
| Last Name Of The Provider | SPURGEON |
| First Name Of The Provider | STEPHEN |
| View All |
Similar Doctors
|
Dr. Jay C. Andersen, MD
 This Doctor is OpenDoctor Recommended.
|
|
Dr. David H. Regan, MD
This Doctor is OpenDoctor Recommended.
|
|
Dr. Gerald M. Segal, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Vinay K. Siddappa, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Renee C. Prins, MD |
|
|
Dr. Keith S. Lanier, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Kathleen A. Drago, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Robert J. Raish, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Marc M. Loriaux, MD
This Doctor is OpenDoctor Recommended.
 This doctor has more publications
|
|
|
Dr. Anthony J. Melaragno, MD |
|
|
Dr. Craig Y. Okada, MD
This Doctor is OpenDoctor Recommended.
This doctor has more publications
|
|
Dr. Angela Kalisiak, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Farnoush Abar, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Rui Li, MD
This Doctor is OpenDoctor Recommended.
|